Diabeloop receives FDA 510 (k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning ...

CV seeks FDA clearance to add AI-based reading to CapsoCam Plus to boost diagnostic accuracy and streamline reviews.

Health tech gadgets displayed at the annual CES trade show make a lot of promises. A smart scale promoted a healthier ...

CapsoVision shares jumped 8.4% to $12.55 on Tuesday. Here are some other big stocks recording gains in today’s session. AXT, ...

What you need to know ### BMJ Learning To obtain accredited continuous professional development points, subscribers to BMJ Learning can complete the full module at The module contains four additional ...

Police received call from Filipino woman’s husband at 4.13pm on Wednesday after she passed out in their Tuen Mun flat.

Key operative among those arrested linked to Pakistan-based handlers, was coordinating delivery of drug consignments across ...

Ultragenyx Pharmaceutical (RARE) has completed the rolling submission of its U.S. marketing application for its gene therapy ...

The moon and sun share top billing in 2026. Kicking off the year's cosmic wonders is the moon, drawing the first astronauts ...

Nexstim’s Therapy Business markets and sells the NBS System 6 which is FDA-cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.